Fox Run Management’s Ascendis Pharma ASND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,613
| Closed | -$493K | – | 792 |
|
|
2024
Q2 | $493K | Buy |
+3,613
| New | +$493K | 0.09% | 415 |
|
|
2024
Q1 | – | Sell |
-2,986
| Closed | -$376K | – | 746 |
|
|
2023
Q4 | $376K | Buy |
+2,986
| New | +$376K | 0.1% | 417 |
|
|
2023
Q2 | – | Sell |
-4,427
| Closed | -$475K | – | 679 |
|
|
2023
Q1 | $475K | Buy |
+4,427
| New | +$475K | 0.15% | 234 |
|